Connect your AI

JELD-WEN JELD Divestiture of businesses, net of cash transferred

Divestiture of businesses, net of cash transferred at other companies

LKQLKQ

$99.25M+3,709%

BioCryst PharmaceuticalsBCRX

-$1.55M—

Community Health SystemsCYH

$1.11B+96.8%

The Baldwin Insurance Group, Inc.BWIN

$0-100%

Republic ServicesRSG

$1M-66.7%

ConstelliumCSTM

-$250K—

Other financials

Income statement

Revenue$722.1M-6.9%

Gross profit$92.7M-17.3%

Operating income-$55.2M+70.1%

Net income-$76.8M+59.6%

EPS (diluted)-$0.90+59.8%

Balance sheet

Cash & equivalents$52.3M-60.7%

Total debt$1.4B+6.3%

Total equity$12.2M-97.3%

Total assets$2.1B-14.1%

Cash flow

Operating cash flow-$91.2M-9.2%

CapEx$25.1M-31.7%

Free cash flow-$116.3M+3.3%

Valuation

Market cap$124.06M-62.0%

Enterprise value$1.5B-5.7%

P/S0×-0.1×

Profitability

Gross margin15.7%-1.8pp

Operating margin-9.1%+1.6pp

Net margin-16.1%+29.2pp

FCF margin5.4%—

Returns & leverage

Return on equity-218.8%-332pp

Debt / equity117.6×+115×

Current ratio1.7×-0.2×

Where this comes from

Reported directly by JELD-WEN in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested.

The official record: JELD-WEN’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about JELD-WEN's divestiture of businesses, net of cash transferred.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is JELD-WEN's divestiture of businesses, net of cash transferred?: JELD-WEN (JELD) reported divestiture of businesses, net of cash transferred of $0 in Q1 2026.
How has JELD-WEN's divestiture of businesses, net of cash transferred changed year-over-year?: JELD-WEN's divestiture of businesses, net of cash transferred decreased by 100.0% year-over-year, from $112.11M to $0.